We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
876
Ollie's Bargain Outlet
OLLI
$5.68B
| $2.58M | ﹤0.01% |
19,541
-5,743
| -23% | -$658K |
2015 Q3
39 quarters
|
|
877
Antero Midstream
AM
$9.46B
| $2.56M | ﹤0.01% |
135,352
-50,048
| -27% | -$894K |
2019 Q3
23 quarters
|
|
|
ALEX
878
DELISTED
Alexander & Baldwin
ALEX
| $2.54M | ﹤0.01% |
142,582
+140,260
| +6,040% | +$2.44M |
2013 Q2
48 quarters
|
|
879
MannKind Corp
MNKD
$1.03B
| $2.52M | ﹤0.01% |
673,739
-665,560
| -50% | -$2.93M |
2024 Q1
5 quarters
|
|
880
Nasdaq
NDAQ
$52.3B
| $2.52M | ﹤0.01% |
28,140
+7,841
| +39% | +$626K |
2019 Q4
22 quarters
|
|
881
Asbury Automotive
ABG
$3.05B
| $2.51M | ﹤0.01% |
10,524
+3,978
| +61% | +$909K |
2022 Q4
10 quarters
|
|
882
DELISTED
Cadence Bank
CADE
| $2.51M | ﹤0.01% |
78,353
-39,475
| -34% | -$1.18M |
2013 Q2
48 quarters
|
|
883
Forrester Research
FORR
$227M
| $2.5M | ﹤0.01% |
252,810
+2,446
| +1% | +$24.3K |
2022 Q4
10 quarters
|
|
884
Glaukos
GKOS
$9.77B
| $2.46M | ﹤0.01% |
23,823
-3,786
| -14% | -$355K |
2023 Q3
7 quarters
|
|
885
Oceaneering
OII
$4.28B
| $2.41M | ﹤0.01% |
116,146
-27,981
| -19% | -$540K |
2013 Q2
48 quarters
|
|
886
FuelCell Energy
FCEL
$1.13B
| $2.4M | ﹤0.01% |
427,862
-103,753
| -20% | -$504K |
2024 Q4
2 quarters
|
|
887
PagerDuty
PD
$1.36B
| $2.38M | ﹤0.01% |
156,058
+138,867
| +808% | +$2.16M |
2025 Q1
1 quarter
|
|
888
Interface
TILE
$2.08B
| $2.37M | ﹤0.01% |
113,458
-20,785
| -15% | -$412K |
2023 Q4
6 quarters
|
|
889
Avista
AVA
$3.03B
| $2.37M | ﹤0.01% |
62,389
+20,504
| +49% | +$809K |
2024 Q3
3 quarters
|
|
890
SIGA Technologies
SIGA
$229M
| $2.37M | ﹤0.01% |
362,961
+1,991
| +0.6% | +$11.9K |
2022 Q4
10 quarters
|
|
891
Novo Nordisk
NVO
$173B
| $2.37M | ﹤0.01% |
34,286
-85,040
| -71% | -$5.78M |
2021 Q2
16 quarters
|
|
892
Parsons
PSN
$4.71B
| $2.34M | ﹤0.01% |
32,592
-1,443
| -4% | -$95.3K |
2022 Q2
12 quarters
|
|
893
Lemonade
LMND
$3.55B
| $2.33M | ﹤0.01% |
+53,250
| New | +$1.77M |
2025 Q2
0 quarters
|
|
894
Curtiss-Wright
CW
$18.5B
| $2.33M | ﹤0.01% |
4,767
+84
| +2% | +$33.2K |
2013 Q2
48 quarters
|
|
895
Minerva Neurosciences
NERV
$116M
| $2.32M | ﹤0.01% |
1,351,275
| – | – |
2014 Q4
42 quarters
|
|
896
NiSource
NI
$19.8B
| $2.32M | ﹤0.01% |
57,604
-15,896
| -22% | -$623K |
2013 Q2
48 quarters
|
|
897
EPR Properties
EPR
$4.22B
| $2.32M | ﹤0.01% |
39,831
-35,122
| -47% | -$1.85M |
2014 Q4
42 quarters
|
|
898
BlackLine
BL
$1.77B
| $2.32M | ﹤0.01% |
40,980
-29,735
| -42% | -$1.54M |
2016 Q4
34 quarters
|
|
899
STAG Industrial
STAG
$6.88B
| $2.3M | ﹤0.01% |
63,483
-56,046
| -47% | -$1.94M |
2019 Q1
25 quarters
|
|
900
Energizer
ENR
$1.51B
| $2.3M | ﹤0.01% |
113,849
-7,938
| -7% | -$191K |
2015 Q3
39 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.